Michelle Robertson - 03 Mar 2022 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
EVP, CHIEF FINANCIAL OFFICER
Signature
/s/ Michelle Robertson
Issuer symbol
EDIT
Transactions as of
03 Mar 2022
Net transactions value
-$13,290
Form type
4
Filing time
07 Mar 2022, 15:15:18 UTC
Previous filing
11 Feb 2022
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale $13,290 -767 -0.9% $17.33 84,194 03 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on December 30, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2022. The sale does not represent a discretionary trade by the Reporting Person.